Nyxoah Stock (NASDAQ:NYXH)
Previous Close
$7.75
52W Range
$5.55 - $11.87
50D Avg
$7.28
200D Avg
$8.56
Market Cap
$289.70M
Avg Vol (3M)
$97.43K
Beta
0.67
Div Yield
-
NYXH Company Profile
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.